Ospedale San Raffaele S.r.l.

31 trials 12 recruiting Academic / non-commercial

Filter these 31 trials by condition, phase, country and more.

Open in Search →

31 Registered trials

12 Recruiting

11 Completed trials

1 Countries active

32 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 19 Phase IV: 7 Phase I (FiH): 2

Oversight events:

2 temporary halts across 2 trials

View oversight register →

100%

11 of 11 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Migraine 1 Type 1 diabetes mellitus 1 Progressive multiple sclerosis 1

Top IMPs

SODIUM CHLORIDE 4 2-[[5-[3-[[6-[[(5S)-5-CARBOXY-5-[[(1S)-1,3-DICARBOXYPROPYL]CARBAMOYLAMINO]PENTYL]AMINO]-6-OXOHEXYL]AMINO]-3-OXOPROPYL]-2-OXIDOPHENYL]METHYL-[2-[[5-(2-CARBOXYETHYL)-2-OXIDOPHENYL]METHYL-(CARBOXYLATOMETHYL)AMINO]ETHYL]AMINO]ACETATE:GALLIUM-68(3+) HYDRON 2 PEMBROLIZUMAB 2 SACITUZUMAB GOVITECAN 2 (3S,10S,14S)-1-[4-[[(2S)-4-CARBOXY-2-[(2S)-4-CARBOXY-2-(6-[18F] FLUOROPYRIDIN-3-AMIDO)BUTANAMIDO]BUTANAMIDO]METHYL]PHENYL]-3-[(NAPHTHALEN-2-YL)METHYL]-1,4,12-TRIOXO-2,5,11,13-TETRAAZAHEXADECANE-10,14,16-TRICARBOXYLIC ACID 1 [99MTC]PSMA I&S 1 BOTULINUM TOXIN TYPE A 1 CANGRELOR TETRASODIUM 1 CISPLATIN 1 DEXAMETHASONE SODIUM PHOSPHATE 1 DMD06-MAB 1 DURVALUMAB 1

All trials — page 2

31 total

Changes in lymph nodes in patients with CLL treated with venetoclax-containing regimens Halted

2024-515938-32-00 Phase IV 1 country
Tirzepatide, a new drug for type 2 diabetes mellitus and obesity, as a possible treatment to modify the clinical evolution of Wolfram syndro… Ended

2024-514909-64-00 Phase II 1 country TIRZEPATIDE
An open label, single-arm, phase 2 study of neoadjuvant sacituzumab govitecan, before radical cystectomy, for patients with muscle-invasive … Ended

2024-515301-26-00 Phase II 1 country SACITUZUMAB GOVITECAN
Myocarditis Therapy with IL-1 inhibitor (MYTH-1): a double-blind, phase IIa, placebo-controlled, randomized clinical trial to evaluate the e… Ended

2024-515472-13-00 Phase II 1 country
The implementation of imaging guidance in surgery for patients with prostate cancer who are candidate to undergo robot-assisted prostatectom… Ended

2024-514583-12-00 Phase II 1 country [99MTC]PSMA I&S; 2-[[5-[3-[[6-[[(5S)-5-CARBOXY-5-[[(1S)-1,3-DICARBOXYPROPYL]CARB…
A study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in patients affected by high-risk prostate cancer Ended

2024-514580-26-00 Phase II 1 country 2-[[5-[3-[[6-[[(5S)-5-CARBOXY-5-[[(1S)-1,3-DICARBOXYPROPYL]CARBAMOYLAMINO]PENTYL…
Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Nonsmall cell lung cancer Ended

2024-516189-12-00 Phase II 1 country

Showing 25–31 of 31 trials

← All sponsors A–Z